Dermatology Times talked with several experts over the course of the Fall Clinical Dermatology meeting to glean practical insights from their presentations.
JAK inhibitors have shown efficacy across several conditions due to the number and role of cytokines in the pathogenesis of these conditions, one expert says.
Dr. Susan Weinkle offers tips to minimize discomfort, which plays a large role in the patient’s perception of outcome.
Dr. Scott Dinehart discusses two newer methods for attacking squamous cell carcinoma, which he says are critical to know.
The shift from antihistamines to newer drugs for treating pruritus is rapidly accelerating. Gil Yosipovitch, M.D. shares the treatments you should know in his presentation at the Fall Clinical Dermatology Conference in Las Vegas.
For many years, genetic expression profiling has helped physicians predict which patients are at the highest risk of having their melanoma metastasize. Now, this same approach could aid in treating squamous cell carcinoma of the skin.
Hilary Baldwin, M.D., discusses the nuances of adult female acne and its treatments in her presentation at the Fall Clinical Dermatology Conference in Las Vegas.
Researcher experiments with reformulating psoriasis topical as a lotion instead of cream, which performed well with patients.
Cosmetic products with prebiotics, probiotics and postbiotics may be beneficial in treating eczema, a physician reported at the Fall Clinical Dermatology Conference held earlier this month in Las Vegas.
Patients are increasingly seeking to have benign lesions removed and today, there are a number of treatment options available to safely and effectively remove unwanted lesions. Suneel Chilukuri, M.D., reviewed these options during a presentation at the Fall Clinical Dermatology Conference held this week in Las Vegas.